Oscar Health, Inc.
OSCR
$31.76
-$1.25-3.79%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.81% | 31.90% | 27.47% | 37.45% | 48.46% |
| Total Other Revenue | 44.02% | 55.57% | 38.96% | 13.74% | -7.19% |
| Total Revenue | 42.82% | 31.95% | 27.50% | 37.38% | 48.29% |
| Cost of Revenue | 37.71% | 36.73% | 36.64% | 46.21% | 57.70% |
| Gross Profit | 67.42% | 13.16% | -8.81% | 4.61% | 15.18% |
| SG&A Expenses | 25.03% | 23.27% | 16.76% | 21.21% | 27.91% |
| Depreciation & Amortization | -7.11% | -6.06% | -10.12% | -1.33% | -5.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.31% | 34.09% | 32.65% | 40.97% | 51.12% |
| Operating Income | 586.40% | -93.72% | -792.15% | -453.40% | -360.76% |
| Income Before Tax | 489.76% | -118.68% | -1,408.25% | -753.41% | -730.66% |
| Income Tax Expenses | 316.62% | -33.46% | -23.26% | -21.06% | 62.52% |
| Earnings from Continuing Operations | 442.92% | -131.73% | -1,795.58% | -924.38% | -980.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.96% | 95.06% | 64.01% | 46.20% | -442.45% |
| Net Income | 441.58% | -131.97% | -1,842.49% | -943.16% | -988.48% |
| EBIT | 586.40% | -93.72% | -792.15% | -453.40% | -360.76% |
| EBITDA | 764.40% | -80.10% | -510.99% | -299.72% | -220.78% |
| EPS Basic | 364.94% | -180.28% | -1,091.30% | -912.09% | -1,433.47% |
| Normalized Basic EPS | 402.09% | -162.68% | -925.55% | -743.38% | -938.36% |
| EPS Diluted | 256.71% | -383.37% | -2,057.25% | -1,959.52% | -600.63% |
| Normalized Diluted EPS | 283.38% | -290.14% | -5,674.21% | -1,418.92% | -454.22% |
| Average Basic Shares Outstanding | 14.51% | 11.72% | 9.14% | 7.87% | 8.46% |
| Average Diluted Shares Outstanding | 14.53% | 2.41% | 1.37% | 0.09% | 0.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |